In fact, the use of oral contraceptives and hormone replacement therapy seems to contribute in some cases to the evolution of the disease, indicating that hormone signaling through both ER and PR receptors is also a factor in BrCa development [125,126]. The gene discussed is ESR1; the disease is invasive breast carcinoma.